Cas:215454-25-4 1-aminoisoquinoline-7-carbonitrile manufacturer & supplier

We serve Chemical Name:1-aminoisoquinoline-7-carbonitrile CAS:215454-25-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-aminoisoquinoline-7-carbonitrile

Chemical Name:1-aminoisoquinoline-7-carbonitrile
CAS.NO:215454-25-4
Synonyms:qc-4280;7-isoquinolinecarbonitrile,1-amino
Molecular Formula:C10H7N3
Molecular Weight:169.18300
HS Code:2933499090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:63.43000
Exact Mass:169.06400
LogP:1.61878

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like qc-4280 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,7-isoquinolinecarbonitrile,1-amino physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,qc-4280 Use and application,7-isoquinolinecarbonitrile,1-amino technical grade,usp/ep/jp grade.


Related News: Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application. 1-aminoisoquinoline-7-carbonitrile manufacturer Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 1-aminoisoquinoline-7-carbonitrile supplier Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development. 1-aminoisoquinoline-7-carbonitrile vendor “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 1-aminoisoquinoline-7-carbonitrile factory Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry.